At least that's what I saw on the news from the CEO of a pharmaceutical company. He said without red tape being cut, they might have it available by the end of the year or early 2021.
At least that's what I saw on the news from the CEO of a pharmaceutical company. He said without red tape being cut, they might have it available by the end of the year or early 2021.